SMTL ID : 5lmb.1 (1 other biounit)

HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x 6ZF: 7-[6-(dimethylamino)pyridin-3-yl]-~{N}-[[(3~{S})-piperidin-3-yl]methyl]pyrido[3,4-b]pyrazin-5-amine(Non-covalent)

6ZF.1: 16 residues within 4Å: Chain A: L.19, V.27, A.42, M.90, E.91, M.92, A.93, E.94, L.95, G.96, P.97, R.140, N.141, L.143, D.154 Ligands: GOL.2 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:L.19, A:L.143 Hydrogen bonds: A:A.93, A:D.154

5 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 5 residues within 4Å: Chain A: L.19, K.29, M.92, E.94 Ligands: 6ZF.1 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.94 GOL.3: 4 residues within 4Å: Chain A: L.227, E.228, G.230, Y.253 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:L.227, A:G.230 Water bridges: A:E.228 GOL.4: 3 residues within 4Å: Chain A: P.72, Y.73, Y.149 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.73, A:Y.73 GOL.5: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP) GOL.6: 1 residues within 4Å: Chain A: R.140 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.140

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Garton, N.S. et al., Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors. Bioorg.Med.Chem.Lett. (2016)

Release Date

2016-09-14

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence